Inventor
SELBY MATTHEW DUNCAN
GB16 patents
⚠️ This page may combine multiple inventors who share the name “SELBY MATTHEW DUNCAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UCB BIOPHARMA SPRL
7 patentsUS9932343B2Apr 3, 2018
Fused tricyclic benzimidazoles derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL10 citations81
US9868749B2Jan 16, 2018
Fused imidazole and pyrazole derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL16 citations81
US9550737B2Jan 24, 2017
TNF -α modulating benzimidazoles
UCB BIOPHARMA SPRL4 citations71
US10202405B2Feb 12, 2019
Fused pentacyclic imidazole derivatives
UCB BIOPHARMA SPRL4 citations70
US9475820B2Oct 25, 2016
Substituted imidazo[1,2-a]pyrazines as TNF activity modulators
UCB BIOPHARMA SPRL3 citations70
US9309243B2Apr 12, 2016
Imidazopyridine derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL4 citations68
US10004737B2Jun 26, 2018
Fused imidazole and pyrazole derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL1 citations51
UCB Biopharma SRL
5 patentsUS10906919B2Feb 2, 2021
Fused pentacyclic imidazole derivatives
UCB Biopharma SRL2 citations70
US11912721B2Feb 27, 2024
Fused pentacyclic imidazole derivatives
UCB Biopharma SRL0 citations60
US12391688B2Aug 19, 2025
Imidazopyridine derivatives as IL-17 modulators
UCB Biopharma SRL0 citations58
US12018021B2Jun 25, 2024
Thiophene derivatives for the treatment of disorders caused by IgE
UCB Biopharma SRL1 citations56
US11052076B2Jul 6, 2021
Spirocyclic indolines as IL-17 modulators
UCB Biopharma SRL0 citations44